Trial Profile

Randomized comparative study on effects of immunosuppression on HCV [hepatitis C virus] recurrence after living donor liver transplantation - comparison between tacrolimus + MMF [mycophenolate mofetil] and tacrolimus + steroid.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 30 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mycophenolate mofetil (Primary) ; Methylprednisolone; Prednisone; Tacrolimus
Indications Liver transplant rejection
Focus Therapeutic Use

13 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
21 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
17 Aug 2010 Planned end date changed from 1 Aug 2008 to 1 Aug 2011 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com